IM Cannabis Corp. (IMCC) Key Metrics

NASDAQ: IMCCValuation, returns, debt and efficiency ratios over 10 years.

IMCC key metrics, 2016–2025

Fiscal year ended December 31, 2025 · Canadian dollars

IMCC returns How much profit the business earns on the capital it uses.

Return on invested capital−19.1 pts
−52.2%
2025 · hover or tap a bar for each year
2016: −0.1% (+0.2 pts)2017: −0.9% (−0.8 pts)2018: 22.4% (+23.2 pts)2019: −74.0% (−96.4 pts)2020: −86.9% (−12.9 pts)2021: −16.6% (+70.4 pts)2022: −19.6% (−3.0 pts)2023: −34.7% (−15.2 pts)2024: −33.1% (+1.6 pts)2025: −52.2% (−19.1 pts)
20162025
Return on assets−7.9 pts
−31.9%
2025 · hover or tap a bar for each year
2019: −47.2%2020: −83.2% (−36.0 pts)2021: −10.9% (+72.3 pts)2022: −108.5% (−97.6 pts)2023: −17.3% (+91.2 pts)2024: −24.1% (−6.7 pts)2025: −31.9% (−7.9 pts)
20162025
Free cash flow margin+10.9 pts
8.6%
2025 · hover or tap a bar for each year
2017: −11.9%2018: −14.9% (−3.0 pts)2019: −82.7% (−67.8 pts)2020: −66.9% (+15.8 pts)2021: −114.4% (−47.5 pts)2022: −26.1% (+88.3 pts)2023: −17.7% (+8.4 pts)2024: −2.3% (+15.5 pts)2025: 8.6% (+10.9 pts)
20162025
Asset turnover+25.7%
1.54
2025 · hover or tap a bar for each year
2016: 0.002017: 932.802018: 225.24 (−75.9%)2019: 0.59 (−99.7%)2020: 0.46 (−21.5%)2021: 0.21 (−54.6%)2022: 0.31 (+49.2%)2023: 0.89 (+185.5%)2024: 1.23 (+37.7%)2025: 1.54 (+25.7%)
20162025

IMCC returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

IMCC debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

IMCC key metrics in Canadian dollars

2016–2025
IM Cannabis Corp. key metrics by fiscal year
2025202420232022202120202019201820172016
Returns & profitability
Return on equity (ROE)—−107.4%−51.2%−168.7%−16.7%−160.5%−41.9%15.6%−1.1%−0.1%
Return on invested capital (ROIC)−52.2%−33.1%−34.7%−19.6%−16.6%−86.9%−74.0%22.4%−0.9%−0.1%
Return on assets (ROA)−31.9%−24.1%−17.3%−108.5%−10.9%−83.2%−47.2%———
Return on tangible assets−39.5%−36.3%−28.9%−439.3%−13.1%−78.2%−24.5%———
Free cash flow margin8.6%−2.3%−17.7%−26.1%−114.4%−66.9%−82.7%−14.9%−11.9%—
Income quality (OCF / net income)———————−0.26——
Financial health
Total debtC$16.3MC$18.0MC$13.8MC$11.5MC$29.3MC$990,000C$1.1M——C$6,441
Cash & short-term investmentsC$2.7MC$863,000C$1.8MC$2.4MC$13.9MC$8.9MC$13.9MC$37,000C$4,026C$170
Net debtC$13.5MC$17.1MC$12.0MC$9.1MC$15.4M−C$7.9M−C$12.9M−C$37,000−C$4,026C$6,271
Debt / equity—3.440.950.510.150.090.04——0.00
Debt / assets0.510.460.280.190.100.030.03——23.34
Net debt / EBITDA————2.46——−0.01——
Current ratio0.670.670.740.971.654.339.310.150.020.00
Quick ratio0.540.580.440.481.042.987.21−21.61−3.080.00
Interest coverage-4.2-2.3-3.5-15.6-34.2-0.4-14.536.7—-30.5
Working capital−C$11.3M−C$11.6M−C$8.6M−C$1.1MC$33.1MC$20.9MC$21.7M−C$214,650−C$456,843−C$431,873
Invested capitalC$12.7MC$22.4MC$26.4MC$31.7MC$216.6MC$3.2MC$11.8MC$10.1MC$11.3MC$11.4M
Tangible asset value−C$6.7M−C$6.9M−C$2.2MC$6.1MC$52.8MC$11.2MC$24.9M−C$218,647−C$456,842−C$431,872
Net current asset value−C$12.6M−C$12.7M−C$10.8M−C$4.2MC$1.9MC$1.6MC$19.5M−C$214,650−C$456,843−C$431,873
Capital allocation
Dividends paidC$0C$0C$0C$0C$0C$0C$0———
Dividends + buybacks / free cash flow0.0%—————————
Capex / revenue0.0%0.3%1.2%2.9%13.5%17.1%17.0%14.0%9.7%—
Capex / operating cash flow0.3%———————81.1%—
Capex / depreciation0.010.070.190.210.802.912.574.055.260.00
Stock-based compensation / revenue0.0%0.7%0.5%6.9%21.9%21.3%29.5%51.5%——
R&D / revenue————0.0%0.9%2.6%1.6%——
SG&A / revenue23.6%24.6%39.0%53.2%82.5%117.8%113.9%48.5%2.8%—
Efficiency
Days sales outstanding98.994.681.7140.1197.889.341.70.60.2—
Days of inventory on hand30.352.8124.4192.6260.2468.6388.41,264.5331.9—
Days payables outstanding94.181.6114.9118.4109.2121.143.788.444.8—
Cash conversion cycle (days)35.265.891.2214.3348.7436.9386.41,176.7287.3—
Receivables turnover3.693.864.472.611.854.098.76592.661,682.820.00
Payables turnover3.884.473.183.083.343.018.364.138.14—
Inventory turnover12.046.912.931.901.400.780.940.291.10—
Asset turnover1.541.230.890.310.210.460.59225.24932.800.00
Average receivablesC$14.8MC$14.0MC$10.9MC$20.9MC$18.5MC$3.9MC$1.0MC$8,769C$2,610C$105
Average payablesC$11.6MC$10.2MC$12.3MC$14.7MC$8.3MC$1.8MC$615,454C$242,046C$195,302C$142,795
Average inventoryC$3.7MC$6.6MC$13.3MC$23.8MC$19.8MC$7.0MC$5.5MC$3.5MC$1.4M—
Intangibles / total assets9.8%25.5%32.6%29.1%53.0%3.7%3.8%10.8%0.0%0.0%

Computed from IMCC's annual financial statements (latest annual report filed March 30, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in Canadian dollars; data from EODHD. Averages use the opening and closing balance of each year.

IMCC valuation and financial ratios

IM Cannabis earned a return on invested capital of −52.2% in fiscal 2025. It ended the year with C$16.3 million of debt and C$2.7 million in cash and short-term investments, net debt of C$13.5 million.

See the IMCC income statement, the IMCC chart for price history, or the IMCC stock overview for the latest quote and news.

IMCC key metrics FAQ

What is IM Cannabis's ROIC?

IM Cannabis's return on invested capital was −52.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does IM Cannabis have?

IM Cannabis had total debt of C$16.3 million at the end of fiscal 2025.

Does IM Cannabis pay a dividend?

IM Cannabis did not pay a dividend in fiscal 2025.

What is IM Cannabis's current ratio?

IM Cannabis's current ratio was 0.67 at the end of fiscal 2025: current assets were 0.67 times current liabilities.

Drug Manufacturers - Specialty & Generic key metrics